Clostridium Botullinum type -A haemagglutin cplx (Apr 2008)
Drug Name:Clostridium Botullinum type -A haemagglutin cplx (Apr 2008)
List Of Brands:
Indication Type Description:
Indication
Indication:
U.S. FDA APPROVED DRUGS FROM 01-01-08 TO 31-12-08
Drug name Indication Date of Approval
115. Clostriium Botulinium type -A toxin 22-04-08
haemagglutinin complex
(Addl.indication)
For focal spaticity,including the treatment of arm
symptoms associated with focal spasticity in
conjuntion with physiotherapy
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Clostridium Botullinum Type A- Toxin 22-04-2008
Haemagglutinium complex
( Additional indication)
For focal spaticcity including the treatment of arm symptoms associated
with focal spasticity in conjunctivitis with physiotherapy
FIXED DOSE COMBINATIONS APPROVED BY DCG(I)
FROM JANUARY 1961 TILL NOVEMBER 2014
Name of Drug Indication Date of Approval
1.Clostridium botulinium toxin type A -Haemagglutin 13-01-1994
Complex 100 units Human serum Albumin 0.5mg+
Nacl 0.9mg
For the treatment of blepharospasm hemifacial spasm &
associated focal dystomina
2.Streprococcus faecalis 30 million + 15-03-2010
Clostridium butyricum 2 million +
Bacillus mesentericus 1 milion +
Lactic acid bacillus 50 million
(lactobacillus sporangenes ) capsules
For restoration of intestinal microflora
3.Streptococcus faecalis T-110 JPC 30 million+ 15-03-2010
Clostridium butyricum 2 million +
bacillus mesentericus TO-A JPC 1 million+
Lactic acid bacillus (lactobacillus sporagenes )
1 million
For restoration of intestinal flora
